Virus

Photo

News • At least 18 years of reduced risk

Cervical cancer: study confirms long-term protection from HPV vaccination

Vaccination against human papillomavirus (HPV) reduces the risk of cervical cancer for at least 18 years, according to a new study. There were no signs of waning protection over time.

Photo

News • Immune response to viral infection

Multiple sclerosis: how EBV can evoke nerve damage

The immune system’s reaction to the common Epstein-Barr virus (EBV) can ultimately damage the brain and contribute to multiple sclerosis (MS), a new study shows.

Photo

News • ‘Reverse genetics’ system

New approach to norovirus vaccine and drug development

Researchers from Osaka have developed a simple and efficient system for understanding the functions of specific norovirus genes, providing new avenues for developing antivirals and vaccines.

Photo

News • From bird flu to pandemic

How Europe can prepare for avian flu spillover

In response to rising H5N1 avian influenza cases in Europe, a new framework aims to help countries detect and respond to spillover to humans – from enhanced surveillance to pandemic preparedness.

Photo

News • Bacteria-eating viruses

New phages spark hope against hospital superbug

A team of researchers comprehensively catalogued a new collection of bacteria-eating viruses called phages. These phages could be used to combat Klebsiella pneumoniae - a serious threat in hospitals.

Photo

News • Cervical cancer prevention

HPV vaccine protects for a long time, study shows

More than a decade of protection against the human papillomavirus (HPV): a new study confirms the long-term effectiveness of the HPV vaccine to prevent development of cervical cancer and pre-cancer.

301 show more articles
Subscribe to Newsletter